SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000921895-20-003015
Filing Date
2020-11-16
Accepted
2020-11-16 16:44:09
Documents
3
Period of Report
2020-11-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K form8k12566001_11162020.htm 8-K 14947
2 PRESS RELEASE ex991to8k12566001_11162020.htm EX-99.1 80719
3 GRAPHIC image_001.jpg GRAPHIC 65667
  Complete submission text file 0000921895-20-003015.txt   187432
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 201317807
SIC: 2834 Pharmaceutical Preparations